16.40
price down icon3.76%   -0.64
after-market Handel nachbörslich: 16.50 0.10 +0.61%
loading

Finanzdaten der Sarepta Therapeutics Inc-Aktie (SRPT)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
10.91%
442.93
399.36 611.09 744.86 658.41
Cost Of Revenue
162.11%
472.04
180.09 250.53 270.90 -
Gross Profit
113.27%
-29.10
219.27 360.56 473.96 -
Operating Expenses
64.90%
829.02
502.75 495.51 1,045.24 496.73
Interest Income/Expense
2,207%
-40.04
1.90 5.228 -4.503 -32.31
Benefits Costs and Expenses
-
- - - 486.67
Costs And Expenses
100.00%
-
502.75 495.51 1,045.24 496.73
Operating Income/Loss
298.09%
-411.58
-103.39 115.58 -300.39 161.68
Nonoperating Income/Loss
247.02%
133.29
-90.66 38.06 -83.13 10.06
Income/Loss From Continuing Operations Before Tax
328.26%
442.93
-194.05 153.64 -383.52 171.74
Income Tax Expense/Benefit
132.27%
4.551
-14.10 -43.25 63.99 12.69
Income/Loss From Continuing Operations After Tax
715.19%
-412.23
-50.57 196.89 -447.51 159.05
Net Income/Loss
715.19%
-412.23
-50.57 196.89 -447.51 159.05
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
98.43%
1.575
100.24 98.00 97.36 0.406
Diluted Average Shares
98.43%
1.575
100.24 106.62 97.36 8.303
Basic Earnings Per Share
686.00%
-3.93
-0.50 2.01 -4.60 1.67
Diluted Earnings Per Share
686.00%
-3.93
-0.50 1.89 -4.60 1.56
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):